Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rare Case of Concomitant Polycythemia Vera and Chronic Lymphocytic Leukemia in a Young Male Patient. | Turk J Haematol | 2023 | 36849726 | PubTator, text mining | PubMed |
| The eukaryotic translation initiation factor eIF4E reprograms alternative splicing. | EMBO J | 2023 | 36843541 | PubTator, text mining | PubMed |
| Development of a Next-generation Sequencing-based Gene Panel Test to Detect Measurable Residual Disease in Acute Myeloid Leukemia. | Ann Lab Med | 2023 | 36843401 | PubTator, text mining | PubMed |
| Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes. | Signal Transduct Target Ther | 2023 | 36843114 | PubTator, text mining | PubMed |
| The Immuno-Oncology and Genomic Aspects of DNA-Hypomethylating Therapeutics in Acute Myeloid Leukemia. | Int J Mol Sci | 2023 | 36835136 | PubTator, text mining | PubMed |
| Microsatellite Instability and Aberrant Pre-mRNA Splicing: How Intimate Is It? | Genes (Basel) | 2023 | 36833239 | PubTator, text mining | PubMed |
| Functional Assessment of a New PBX1 Variant in a 46,XY Fetus with Severe Syndromic Difference of Sexual Development through CRISPR-Cas9 Gene Editing. | Genes (Basel) | 2023 | 36833200 | PubTator, text mining | PubMed |
| Deepening Our Understanding of the Factors Affecting Landscape of Myeloproliferative Neoplasms: What Do We Know about Them? | Cancers (Basel) | 2023 | 36831689 | PubTator, text mining | PubMed |
| Molecular Drivers of Myelodysplastic Neoplasms (MDS)-Classification and Prognostic Relevance. | Cells | 2023 | 36831294 | PubTator, text mining | PubMed |
| Targeted Therapy Development in Acute Myeloid Leukemia. | Biomedicines | 2023 | 36831175 | PubTator, text mining | PubMed |
| Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. | Curr Oncol | 2023 | 36826113 | PubTator, text mining | PubMed |
| Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study. | Leukemia | 2023 | 36823396 | PubTator, text mining | PubMed |
| Long non-coding RNA in glioma: novel genetic players in temozolomide resistance. | Anim Cells Syst (Seoul) | 2023 | 36819921 | PubTator, text mining | PubMed |
| Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea. | Hum Genomics | 2023 | 36814285 | PubTator, text mining | PubMed |
| MDS subclassification-do we still have to count blasts? | Leukemia | 2023 | 36813994 | PubTator, text mining | PubMed |
| Sex Disparities in Myelodysplastic Syndromes: Genotype, Phenotype, and Outcomes. | Clin Lymphoma Myeloma Leuk | 2023 | 36813626 | PubTator, text mining | PubMed |
| Splice site m6A methylation prevents binding of DGCR8 to suppress KRT4 pre-mRNA splicing in oral squamous cell carcinoma. | PeerJ | 2023 | 36811004 | PubTator, text mining | PubMed |
| FixItFelix: improving genomic analysis by fixing reference errors. | Genome Biol | 2023 | 36810122 | PubTator, text mining | PubMed |
| Monocyte, neutrophil, and whole blood transcriptome dynamics following ischemic stroke. | BMC Med | 2023 | 36803375 | PubTator, text mining | PubMed |
| Diagnosis, treatment, and genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A review. | Medicine (Baltimore) | 2023 | 36800625 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=30